Holen Sie sich die Stockscreener-App
23.08
2.45%
-0.58
Castle Biosciences Inc Aktie (CSTL) Neueste Nachrichten
Risk adjusted return profile for Castle Biosciences Inc. analyzedProfit Target & Daily Oversold Bounce Ideas - newser.com
How high can Castle Biosciences Inc. stock go2025 Key Highlights & Weekly High Return Opportunities - newser.com
Using data tools to time your Castle Biosciences Inc. exitMarket Performance Report & Daily Price Action Insights - newser.com
Is Castle Biosciences Inc. stock poised for growthDividend Hike & Proven Capital Preservation Tips - newser.com
Is this a good reentry point in Castle Biosciences Inc.July 2025 PostEarnings & Consistent Return Investment Signals - newser.com
What drives Castle Biosciences Inc stock priceCup and Handle Formations & Free Expert Stock Watchlists - earlytimes.in
How to integrate Castle Biosciences Inc. into portfolio analysis toolsMarket Performance Summary & Stepwise Entry/Exit Trade Alerts - newser.com
Weiss Ratings Reiterates "Sell (E+)" Rating for Castle Biosciences (NASDAQ:CSTL) - MarketBeat
Castle Biosciences Forms Golden Cross, Signaling Potential Bullish Breakout - Markets Mojo
Castle Biosciences CEO Maetzold sells $30,234 in shares - Investing.com
Will Castle Biosciences Inc. stock pay special dividendsGDP Growth & Weekly Top Gainers Trade List - newser.com
How Castle Biosciences Inc. stock reacts to Fed rate cuts2025 Price Action Summary & Weekly Market Pulse Alerts - newser.com
Order flow analysis tools used on Castle Biosciences Inc.2025 Pullback Review & Daily Stock Trend Reports - newser.com
Analyzing net buyer seller activity in Castle Biosciences Inc.Trade Volume Summary & Verified Technical Trade Signals - newser.com
Is Castle Biosciences Inc a good long term investmentBollinger Bands Signals & Low Risk Investment Growth - earlytimes.in
Castle Biosciences’ Founder, President and CEO Derek Maetzold Honored with the CEO of the Year Award by The CEO Magazine - markets.businessinsider.com
Castle Biosciences’ Founder, President and CEO Derek - GlobeNewswire
Selected from 586 Executives: Castle Biosciences' Derek Maetzold Crowned CEO of the Year 2025 - Stock Titan
User - FinancialContent
Castle Biosciences, Inc. (NASDAQ:CSTL) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat
What analysts say about Castle Biosciences Inc stockSmall Cap Stock Opportunities & High Profit Market Tips - Early Times
Strs Ohio Takes $366,000 Position in Castle Biosciences, Inc. $CSTL - MarketBeat
Castle Biosciences Honored with a Greater Pittsburgh Top Workplaces 2025 Award - markets.businessinsider.com
SciBase Receives Initial Order for Clinical Study From Castle Biosciences - 富途牛牛
Castle Biosciences (NASDAQ:CSTL) Insider Sells $29,417.83 in Stock - MarketBeat
Castle Biosciences, Inc. $CSTL Shares Sold by Goldman Sachs Group Inc. - MarketBeat
Diagnostic Testing Leader Castle Biosciences Secures 9th Workplace Award in 2025, Including Pittsburgh Honor - Stock Titan
SciBase receives initial order for clinical study from Castle Biosciences - Yahoo Finance
Scibase receives initial order for clinical study from Castle Biosciences - MarketScreener
Inspire Investing LLC Has $343,000 Holdings in Castle Biosciences, Inc. $CSTL - MarketBeat
Activity Recap: Does Castle Biosciences Inc have declining or rising EPSShare Buyback & Stepwise Trade Execution Plans - khodrobank.com
Risks Report: Can Castle Biosciences Inc deliver alphaJuly 2025 Chart Watch & High Conviction Buy Zone Picks - khodrobank.com
Aug Breakouts: How liquid is Castle Biosciences Inc stockJuly 2025 Spike Watch & Daily Entry Point Trade Alerts - خودرو بانک
Castle Biosciences Reports Strong Q2 2025 Financial Results - MSN
0.17%
2.19%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):